Avandia
NDC 54868-4198
Product Information
Avandia is a NDA-approved product labeled by Physicians Total Care, Inc.. Rosiglitazone is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It is supplied as a pink product. This product entry covers the primary NDC 54868-4198 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
ORANGE (C48331)
SB;2
SB;4
Code Structure Chart
Product Details
What is NDC 54868-4198?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ROSIGLITAZONE MALEATE (UNII: KX2339DP44)
- ROSIGLITAZONE (UNII: 05V02F2KDG) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYPROMELLOSE 2910 (3 CPS) (UNII: 0VUT3PMY82)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL 3000 (UNII: SA1B764746)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- TALC (UNII: 7SEV7J4R1U)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 261241 - Avandia 2 MG Oral Tablet
- RxCUI: 261241 - rosiglitazone 2 MG Oral Tablet [Avandia]
- RxCUI: 261241 - Avandia 2 MG (as rosiglitazone maleate) Oral Tablet
- RxCUI: 261242 - Avandia 4 MG Oral Tablet
- RxCUI: 261242 - rosiglitazone 4 MG Oral Tablet [Avandia]
* Please review the full disclaimer at the bottom of this page.